• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人巨噬细胞对蛋白聚糖选择的低密度脂蛋白亚组分的差异摄取。

Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.

作者信息

Hurt-Camejo E, Camejo G, Rosengren B, Lopez F, Wiklund O, Bondjers G

机构信息

Wallenberg Laboratory for Cardiovascular Research, University of Göteborg, Sahlgren's Hospital, Sweden.

出版信息

J Lipid Res. 1990 Aug;31(8):1387-98.

PMID:2280180
Abstract

Macrophages and arterial chondroitin sulfate proteoglycans (CSPG) are probably associated with extracellular and intracellular lipoprotein deposition during atherogenesis. We found that human arterial CSPG can be used to select subclasses from low density lipoprotein (LDL) with different structural properties and capacities to interact with human monocyte-derived macrophages (HMDM). Four subclasses, LDL(PG)1 to LDL(PG)4, in order of decreasing CSPG-complexing capacity, were prepared and characterized in terms of their ability to interact with HMDM. The LDL subclasses with highest avidity for CSPG, LDL(PG)1 and LDL(PG)2, were bound, internalized, and degraded more efficiently than those of lower avidity for CSPG. From LDL(PG)1 to LDL(PG)4, the gradual decrease in uptake by HMDM and decreasing avidity for CSPG were associated with a gradual decrease in isoelectric point (from 5.93 to 5.68) and an augmented ratio of surface polar lipid to core nonpolar components (from 0.35 to 0.54). Competition experiments indicated that the proteoglycan-selected subfractions shared the binding sites and uptake mechanisms of native LDL. The results suggest the existence of a structurally related gradation in the avidity of LDL subpopulations for cells and matrix components. The presence within LDL subpopulations of a differential capacity to interact with intimal extracellular and cellular elements could be associated with a similar heterogeneity in their atherogenic potential.

摘要

巨噬细胞和动脉硫酸软骨素蛋白聚糖(CSPG)可能与动脉粥样硬化形成过程中的细胞外和细胞内脂蛋白沉积有关。我们发现,人类动脉CSPG可用于从低密度脂蛋白(LDL)中选择具有不同结构特性和与人单核细胞衍生巨噬细胞(HMDM)相互作用能力的亚类。制备了四个亚类,即LDL(PG)1至LDL(PG)4,按照与CSPG结合能力递减的顺序排列,并根据它们与HMDM相互作用的能力进行了表征。与CSPG亲和力最高的LDL亚类,即LDL(PG)1和LDL(PG)2,比与CSPG亲和力较低的亚类更有效地被结合、内化和降解。从LDL(PG)1到LDL(PG)4,HMDM摄取的逐渐减少以及对CSPG亲和力的降低与等电点的逐渐降低(从5.93降至5.68)和表面极性脂质与核心非极性成分的比例增加(从0.35增至0.54)相关。竞争实验表明,蛋白聚糖选择的亚组分共享天然LDL的结合位点和摄取机制。结果表明,LDL亚群对细胞和基质成分的亲和力存在结构相关的梯度。LDL亚群中与内膜细胞外和细胞成分相互作用的差异能力的存在可能与其致动脉粥样硬化潜力的类似异质性有关。

相似文献

1
Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.人巨噬细胞对蛋白聚糖选择的低密度脂蛋白亚组分的差异摄取。
J Lipid Res. 1990 Aug;31(8):1387-98.
2
Modifications of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate.动脉蛋白聚糖和硫酸软骨素-6诱导的低密度脂蛋白修饰
Biochim Biophys Acta. 1991 Apr 15;1096(3):253-61. doi: 10.1016/0925-4439(91)90013-y.
3
Interaction of LDL with human arterial proteoglycans stimulates its uptake by human monocyte-derived macrophages.低密度脂蛋白(LDL)与人动脉蛋白聚糖的相互作用会刺激人单核细胞衍生巨噬细胞对其摄取。
J Lipid Res. 1990 Mar;31(3):443-54.
4
Macrophage plasma membrane chondroitin sulfate proteoglycan binds oxidized low-density lipoprotein.巨噬细胞质膜硫酸软骨素蛋白聚糖结合氧化型低密度脂蛋白。
Atherosclerosis. 2000 Mar;149(1):5-17. doi: 10.1016/s0021-9150(99)00287-7.
5
Low-density lipoprotein binding affinity of arterial chondroitin sulfate proteoglycan variants modulates cholesteryl ester accumulation in macrophages.动脉硫酸软骨素蛋白聚糖变体的低密度脂蛋白结合亲和力调节巨噬细胞中胆固醇酯的积累。
Biochim Biophys Acta. 1995 Aug 15;1272(1):61-7. doi: 10.1016/0925-4439(95)00068-f.
6
Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans.蛋白聚糖和糖胺聚糖对铜催化的低密度脂蛋白氧化的修饰作用。
J Lipid Res. 1991 Dec;32(12):1983-91.
7
Low-density lipoprotein binding affinity of arterial wall proteoglycans: characteristics of a chondroitin sulfate proteoglycan subfraction.动脉壁蛋白聚糖的低密度脂蛋白结合亲和力:硫酸软骨素蛋白聚糖亚组分的特征
Biochim Biophys Acta. 1989 Nov 28;1006(2):159-66. doi: 10.1016/0005-2760(89)90190-2.
8
Binding parameters and concentration modulate formation of complexes between LDL and arterial proteoglycans in serum.结合参数和浓度调节血清中低密度脂蛋白(LDL)与动脉蛋白聚糖之间复合物的形成。
Atherosclerosis. 1989 Oct;79(2-3):121-8. doi: 10.1016/0021-9150(89)90116-0.
9
Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating factor that differ in their ability to bind low density lipoproteins.人单核细胞衍生的巨噬细胞分泌两种形式的蛋白聚糖 - 巨噬细胞集落刺激因子,它们结合低密度脂蛋白的能力不同。
J Biol Chem. 1998 Jun 26;273(26):15985-92. doi: 10.1074/jbc.273.26.15985.
10
Isolation and characterization of a proteoglycan variant from human aorta exhibiting a marked affinity for low density lipoprotein and demonstration of its enhanced expression in atherosclerotic plaques.从人主动脉中分离并鉴定一种对低密度脂蛋白具有显著亲和力的蛋白聚糖变体,并证明其在动脉粥样硬化斑块中表达增强。
Atherosclerosis. 1996 Dec 20;127(2):195-203. doi: 10.1016/s0021-9150(96)05954-0.

引用本文的文献

1
A novel assay to measure low-density lipoproteins binding to proteoglycans.一种测量低密度脂蛋白与蛋白聚糖结合的新方法。
PLoS One. 2024 Jan 31;19(1):e0291632. doi: 10.1371/journal.pone.0291632. eCollection 2024.
2
Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases.代谢综合征:从氧化应激到相关疾病管理的叙述性综述
Antioxidants (Basel). 2023 Dec 8;12(12):2091. doi: 10.3390/antiox12122091.
3
Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational study.
预估 sdLDL-C 用于预测银屑病患者的高危冠状动脉斑块特征:一项前瞻性观察研究。
Lipids Health Dis. 2023 Apr 27;22(1):55. doi: 10.1186/s12944-023-01819-x.
4
Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart Disease.载脂蛋白颗粒数与粒径的相互作用与冠心病风险。
Clin Chem. 2023 Jan 4;69(1):48-55. doi: 10.1093/clinchem/hvac172.
5
LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL.载脂蛋白 B 致动脉粥样硬化性血脂异常的 LDL 亚类脂质组学:他汀类药物治疗对生物活性脂质和致密 LDL 的影响。
J Lipid Res. 2020 Jun;61(6):911-932. doi: 10.1194/jlr.P119000543. Epub 2020 Apr 15.
6
Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study.小而密低密度脂蛋白与冠心病合并糖尿病患者心血管结局的相关性:一项前瞻性观察队列研究。
Cardiovasc Diabetol. 2020 Apr 3;19(1):45. doi: 10.1186/s12933-020-01015-6.
7
A comparative pharmacogenomic analysis of three classic TCM prescriptions for coronary heart disease based on molecular network modeling.基于分子网络建模的三种经典冠心病中药方剂的比较药物基因组学分析。
Acta Pharmacol Sin. 2020 Jun;41(6):735-744. doi: 10.1038/s41401-019-0352-3. Epub 2020 Feb 12.
8
Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.载脂蛋白 B 颗粒与心血管疾病:一篇叙述性综述。
JAMA Cardiol. 2019 Dec 1;4(12):1287-1295. doi: 10.1001/jamacardio.2019.3780.
9
Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors.体重变化对载脂蛋白 B 所致新兴动脉粥样硬化性心血管疾病(ASCVD)危险因素的影响。
Lipids Health Dis. 2019 Jul 17;18(1):154. doi: 10.1186/s12944-019-1094-4.
10
Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial.一种营养保健品组合对代谢综合征患者脂代谢的疗效:一项多中心、双盲、随机、安慰剂对照试验。
Lipids Health Dis. 2019 Mar 18;18(1):66. doi: 10.1186/s12944-019-1002-y.